SECURITY Did Not Establish Noninferiority

In presenting the results of the SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy) trial, Colombo et al. [(1)][1] concluded that “6 months of DAPT appeared noninferior to a 12-month regimen with respect to the primary composite